Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been retracted at the request of the Editor-in-Chief.An Expression of Concern for this article was previously published while an investigation was conducted (see related editorial: https://doi.org/10.1016/j.biopha.2022.113812). This retraction notice supersedes the Expression of Concern published earlier.Concern was raised about the reliability of the images in Figure 5B, and the Western blots shown in Figure 9A+B, which appear to contain similar repeated features, and a phenotype found in other publications, as detailed here: https://pubpeer.com/publications/81D7B72D646EC532D0DFF63338A55F; and here: https://docs.google.com/spreadsheets/d/1r0MyIYpagBc58BRF9c3luWNlCX8VUvUuPyYYXzxWvgY/edit#gid=262337249. Independent analysis confirmed these findings and identified additional suspected image duplications in Figures 5A+B and 9A+B. The journal requested the corresponding author comment on these concerns and provide the associated raw data. The authors did not respond to this request and therefore the Editor-in-Chief decided to retract the article.

WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytoma

WITHDRAWN: LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma

WITHDRAWN: Discovery of a potent inhibitor that suppresses glioblastoma by dual targeting of both syntenin PDZ domains

WITHDRAWN: Dual Targeting of Glioma U251 Cells and Neovasculature with a Nanoparticle Encoding Vasohibin and RGD Peptides Prevents Tumor Angiogenesis and Inhibits Tumor Growth

WITHDRAWN: The Molecular Signature Associated with Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer

WITHDRAWN: Proteonano™ coupled with Orbitrap Astral™: A robust and standardized workflow for large-cohort clinical plasma proteomics studies

WITHDRAWN: <i>MiR-760</i> inhibits the progression of non-small cell lung cancer through blocking <i> <i>ROS1</i> </i>/Ras/Raf/MEK/ERK pathway

WITHDRAWN: DiDBiT-TMT: A novel method to quantify changes in the proteomic landscape induced by neural plasticity

WITHDRAWN: Dynamic Regulation of MAVS Protein Function via Reversible Oxidation at Cys in Response to Oxidant Stimuli

Withdrawal Notice: Roles of Aryl-hydrocarbon Receptor in Metabolism and Proliferative Behaviors of Bone Marrow Mscs: Implications for Targeted Therapy

WITHDRAWN: Bioinformatic Analysis of the Roles of CDK2 in Neuroblastoma

Withdrawal: Advances in Development of Drugs for Chronic Myelogenous Leukemia

WITHDRAWN: -serine protease-like protein B (SplB) activates PAR2 and induces endothelial barrier dysfunction

RETRACTED: the Effects of the Long Non-Coding RNA MALAT-1 Regulated Autophagy-Related Signaling Pathway on Chemotherapy Resistance in Diffuse Large B-cell Lymphoma

Retinoic acid-incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells

WITHDRAWN: Radiation-induced non-neoplastic cells senescence promoting the proliferation and invasiveness of GBM through SASP/JAK2-STAT3 Pathway

WITHDRAWN: Rad5 and Rad51 act at telomeres through two partially distinct pathways

Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

Retracted: Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells In Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway

WITHDRAWN: The adhesion GPCR Adgrd1 is a prion protein receptor and a mediator of prion cytotoxicity

RETRACTION: Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 Via NFKB1 Transcriptional Factor